pop up description layer

ISAP Researchers' Profiles

M. Douglas Anglin, Ph.D.

M. Douglas Anglin (Ph.D. in Social Psychology, UCLA, 1980) was the Founding Director of the UCLA Drug Abuse Research Center (1984-1997) has been an Associate Director of ISAP since 1998. Dr. Anglin has been conducting research on substance abuse epidemiology, etiology, treatment evaluation, and social policy since 1972. He has been Principal Investigator on more than 25 federally funded studies and numerous state- and foundation-supported studies. Over his career he has been the author or co-author of more than 200 published articles. Dr. Anglin has served as an advisor to many national treatment evaluation studies, including the Drug Abuse Treatment Outcome Study and the Federal Bureau of Prisons Drug Programs Evaluation Project. He has also served as consultant to the following agencies: National Institute on Drug Abuse, Office of National Drug Control Policy, Center for Substance Abuse Treatment, National Academy of Sciences Institute of Medicine, National Institute of Justice, California Youth Authority and Departments of Alcohol and Drug Programs and Corrections, and Los Angeles County Alcohol and Drug Program Administration. 

Education and Training

  • University of Arkansas, Fayetteville, B.A., Chemistry, 1969
  • University of California, Los Angeles, M.A., Psychology, 1970
  • University of California, Los Angeles, Ph. D., Social Psychology, 1980

Specialties

  • Drug Abuse: Etiology, Epidemiology, Treatment, Treatment Evaluation, Substance Abusing Offenders, Research Methodology, Social Policy

Contact Info

UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Suite 200
Los Angeles, CA 90025
doug_anglin@hotmail.com

Selected Publications

(Publications selected from more than 225 publications)

  • Hser, Y.-I., Anglin, M.D., Grella, C.E., Longshore, D., & Prendergast, M L. (1997).  Drug treatment careers: A conceptual framework and existing research findings. Journal of Substance Abuse Treatment, (14)6, 543-558.
  • Farabee, D., Prendergast, M.L., & Anglin, M.D. (1998) The effectiveness of coerced treatment for drug-abusing offenders. Federal Probation, 62, 3-10.
  • Kasarabada, N. D., Anglin, M. D., Khalsa-Denison, E., & Paredes, A. (1998). Variations in psychosocial functioning associated with patterns of progression in cocaine-dependent men. Addictive Behaviors, 23(2), 179-189.   
  • Longshore, D., Annon, J., & Anglin, M.D. (1998).  HIV Prevalence among injection drug users in three Northern California communities.  Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19, 200.
  • Longshore, D., Turner, S., & Anglin, M.D. (1998).  Effects of case management on drug users’ risky sex.  The Prison Journal, 78, 6-30.
  • Polinsky, M. L., Hser, Y., Anglin, M. D., & Maglione, M. A. (1998). Drug-user treatment programs in a large metropolitan area. Substance Use and Misuse, 33(8), 1739-1761.
  • Anglin, M. D., & Perrochet, B. (1998). Drug use and crime: A historical review of research conducted by the UCLA Drug Abuse Research Center. Substance Use and Misuse, 33(9), 1871-1914.
  • Hser, Y., Chou, C.P., Hoffman, V., & Anglin, M.D. (1999). Cocaine use and high-risk sexual behavior among STD clinic patients. Sexually Transmitted Diseases, 26(2), 82-86.
  • Farabee, D., Prendergast, M., Cartier, J., Wexler, H., Knight, K., & Anglin, M.D. (1999) Barriers to implementing effective correctional drug treatment programs. Prison Journal, 79(2), 150-162.
  • Grella, C. E., Hser, Y.I., Joshi, V., & Anglin, M. D. (1999). Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug and Alcohol Dependence, 57(2), 151-166. 
  • Maglione, M.A., Chao, B., & Anglin, M.D. (2000). Residential treatment of methamphetamine users: Correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994-1997. Addiction Research, 8(1), 65-79.
  • Shaw, V. N., Hser. Y.I., Anglin, M. D., & Boyle, K. (1999). Sequences of powder cocaine and crack use among arrestees in Los Angeles County. American Journal of Drug and Alcohol Abuse, 25(1), 47-66.
  • Simpson, D.D., Joe, G.W., Fletcher, B.W., Hubbard, R.L., & Anglin, M.D. (1999). A national evaluation of treatment outcomes for cocaine dependence.  Archives of General Psychiatry, 56, 507-514.
  • Simpson, D.D., Joe, G.W., Fletcher, B.W., Hubbard, R.L., & Anglin, M.D. (1999). A national evaluation of treatment outcomes for cocaine dependence.  Archives of General Psychiatry, 56, 507-514.
  • Anglin, M.D., & Rawson, R.A. (Eds.). (2000). The CSAT methamphetamine treatment project: Moving research into the "real world." Journal of Psychoactive Drugs, 32(2), 221-228.
  • Brecht, M.-L., von Mayrhauser, C.V., & Anglin, M.D. (2000). Predictors of relapse after treatment for methamphetamine use. Journal of Psychoactive Drugs, 32(2), 211-220.
  • Grella, C.E., Annon, J.J., & Anglin, M.D. (2000). Drug use and risk for HIV among women arrestees in California. AIDS and Behavior, 4(3), 289-295.
  • Grella, C.E., Etheridge, R., Joshi, V., & Anglin, M.D. (2000).  Delivery of HIV risk-reduction services in drug treatment programs.  Journal of Substance Abuse Treatment, 19(3), 229-237.
  • Farabee, D., Joshi, V., & Anglin, M.D. (2001). Addiction careers and criminal specialization. Crime & Delinquency, 47(2), 196-220.
  • Farabee, D., Shen, H., Hser Y., Grella, C.E., & Anglin, M.D. (2001). The effect of drug treatment on adolescent criminal behavior.  Journal of Adolescent Research. 16(6), 679-696.
  • Flynn, P.M., Simpson, D.D., Anglin, M.D., & Hubbard, R.L. (2001).  Comment on “nonresponse and selection bias in treatment follow-up studies.”  Substance Use and Misuse, 36(12), 1749-51, 1753-7.
  • Hser, Y., Grella, C.E., Hubbard, R.L., Hsieh, S.C., Fletcher, B.W., Brown, B.S., & Anglin, M.D. (2001).  An evaluation of drug treatments for adolescents in four U.S. cities. Archives of General Psychiatry, 58, 689-695.
  • Hser, Y., Shen, H., Chou, C.-P., Messer, S., & Anglin, M.D. (2001). Analytic approaches for assessing long-term treatment effects:  Examples of empirical applications and findings.  Evaluation Review, 25(2), 233-262.
  • Hser, Y., & Anglin, M. D. (2002). Book review [Review of the book Making research relevant and beyond. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment]. Contemporary Psychology: APA Review of Books, 47(1), 75-78.
  • Von Mayrhauser, C., Brecht, M.L., & Anglin, M.D. (2002).  Use ecology and drug use motivations of methamphetamine users admitted to substance treatment facilities in Los Angeles: An emerging profile.  Journal of Addictive Diseases, 21(1), 45-60.
  • Riehman, K.S., Iguchi, M.Y., & Anglin, M.D. (2002). Depressive symptoms among amphetamine and cocaine users before and after substance use treatment. Psychology of Addictive Behaviors, 16(4), 333-337. 
  • Grella, C.E., Joshi, V., & Anglin, M.D. (2003). Gender differences and treatment outcomes among methadone maintenance patients in DATOS.  Journal of Maintenance in the Addictions, 2(1/2), 103-128.
  • Hser, Y.-I., Huang, D., Chou, C.-P., Teruya, C., & Anglin, M D. (2003). Longitudinal patterns of treatment utilization and outcomes among methamphetamine abusers: A growth curve modeling approach. Journal of Drug Issues, 33, 921-938.
  • Rawson, R.A., Marinelli-Casey, P., Anglin, M.D., et al. (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99, 708-717.
  • Hser, Y.-I., Huang, D., Teruya, C., & Anglin, M.D. (2004). Diversity of drug abuse treatment utilization patterns and outcomes. Evaluation and Program Planning, 27, 309-319.
  • Brecht, M.-L., O'Brien, A., Mayrhauser, C., & Anglin, M. D. (2004). Methamphetamine use behaviors and gender differences. Addictive Behaviors, 29, 89-106.
  • Hser, Y.-I., Huang, Y.-C., Teruya, C., & Anglin, M. D. (2004). Gender differences in treatment outcomes over a three-year period: A path model analysis. Journal of Drug Issues, 34, 419-440.
  • Brecht, M.-L., Anglin, M. D., & Dylan, M. (2005). Coerced treatment for methamphetamine abuse: Differential patient characteristics and outcomes. American Journal of Drug and Alcohol Abuse, 31, 337-356.
  • Brecht, M.L., Greenwell, L., & Anglin, M. D. (2005). Methamphetamine treatment: Trends and predictors of retention and completion in a large state treatment system (1992-2002). Journal of Substance Abuse Treatment, 29, 295-306.
  • Longshore, D., Annon, J., Anglin, M D., & Rawson, R.A. (2005). Levo-alpha-acetylmethadol (LAAM) versus methadone: Treatment retention and opiate use. Addiction, 100(8), 1131-1139.

Last updated - 06/22/2007

Click here to view other profiles.

Top of Page
UCLA Home Page ISAP Home Page